We present an automated high-throughput method to quantify neutrophil extracellular traps (NETs) utilizing the live cell analysis system, coupled with a membrane permeability-dependent dual-dye approach.
Neutrophils are myeloid-lineage cells that form a crucial part of the innate immune system. The past decade has revealed additional key roles that neutrophils play in the pathogenesis of cancer, autoimmune diseases, and various acute and chronic inflammatory conditions by contributing to the initiation and perpetuation of immune dysregulation through multiple mechanisms, including the formation of neutrophil extracellular traps (NETs), which are structures crucial in antimicrobial defense. Limitations in techniques to quantify NET formation in an unbiased, reproducible, and efficient way have restricted our ability to further understand the role of neutrophils in health and diseases. We describe an automated, real-time, high-throughput method to quantify neutrophils undergoing NET formation using a live cell imaging platform coupled with a membrane permeability-dependent dual-dye approach using two different DNA dyes to image intracellular and extracellular DNA. This methodology is able to help assess neutrophil physiology and test molecules that can target NET formation.
Neutrophil extracellular traps (NETs) are web-like chromatin structures extruded from neutrophils in response to various inflammatory stimuli. NETs are composed of DNA, histones, and various anti-microbial proteins/peptides, which trap and kill infectious pathogens and invoke inflammatory responses1.
While NETs are beneficial for host defense against pathogens, they have gathered attention as a potential driver of various autoimmune diseases2, thrombosis3, metabolic diseases4, and metastatic growth of cancers5. As such, inhibition of NET formation is a potential therapeutic option for these diseases. However, despite some promising NETs-targeting molecules in development6, there is still no approved therapy that specifically affects this mechanism. This is, at least partially, attributable to the lack of objective, unbiased, reproducible, and high throughput quantification methods for NET formation.
We established and reported a new method utilizing a dual-color live-cell imaging platform7,8. Time-lapse images of neutrophils stained with membrane-permeable nuclear dye and membrane-impermeable DNA dye are analyzed by the software, and the numbers of pre- and post-NET-forming neutrophils are counted at multiple time points. Since the integrity of the plasma membrane is lost during NET formation by the regulation of PKCα-mediated Lamin B and CDK4/6-mediated Lamin A/C disassembly9, NET-forming neutrophils are stained by membrane-impermeable DNA dye while healthy neutrophils are not. This method overcomes the problems of previously reported techniques to quantify NET formation and provides unbiased, high-throughput, reproducible, and accurate NET quantification in an automated manner.
Neutrophils from healthy human subjects were obtained after informed consent was provided under National Institutes of Health (NIH) Institutional Review Board (IRB) approved protocol. The protocol follows guidelines of NIH human research ethics committee.
1. Staining of the neutrophils and preparation of assay plate
2. Scanning plate to visualize NET-forming neutrophils
3. Setting the analysis definition to quantify NETs
This method provides phase contrast, red fluorescent (membrane-permeable dye) and green fluorescent (membrane-impermeable dye) images taken at each timepoint. Along with the NET-forming process, morphological changes are observed in phase contrast and red fluorescent images, and once the membrane is breached, green fluorescence can be observed (Figure 1). In this assay, NET-forming neutrophils are generally round, instead of forming web-like structure. This is because the resolution of the machine is not high enough to capture fine web-like structure and membrane impermeable green dye stains chromatin before it is released once the membrane is breached. We have previously shown7 that NETs can be visualized by use of confocal imaging in the 96-well plates retrieved after 4 h incubation.
When the analysis definition is appropriately set, all neutrophils in the image are marked as red object and NET-forming neutrophils are marked as green object (Figure 2). The machine counts the number of red and green objects at each time point. The time course of NET formation is visualized by plotting the percentage of NET-forming neutrophils at each time point (Figure 3). Potential molecules that target NET formation (e.g., AKT inhibitor) may be tested in a high throughput manner using this methodology.
Figure 1: Morphological changes in neutrophils undergoing NET formation. (A) Human peripheral blood neutrophils that were stimulated with 2.5 µM calcium ionophore for 3 h. (B) Representative single-cell views of phase contrast image, red channel (membrane-permeable nuclear dye), green channel (membrane-impermeable DNA dye), and merged image. Please click here to view a larger version of this figure.
Figure 2: Representative images showing software recognition of neutrophils and NETs. Neutrophils from human healthy volunteers were stimulated with 2.5 µM calcium ionophore for 1 h. Overlaid images of phase contrast imaging and each signal or mask are shown. Nuclei were stained with (A) membrane-permeable red dye, and the software recognized and counted (B) nuclei marked blue while the NETs were stained with (C) membrane-impermeable green dye and the software marked them as (D) purple. If (E) oversensing or (F) under sensing occurs, parameter may need to be changed. Please click here to view a larger version of this figure.
Figure 3: Time course of the percentage of NET-forming neutrophils. Neutrophils were stimulated by 25 nM phorbol 12-myristate 13-acetate (PMA) or 2.5 µM calcium ionophore to induce NETs or left unstimulated in RPMI. Addition of 30 µM AKT inhibitor was done to block NET formation. Images were obtained by the software every 20 min for 6 h. The percentage of NET-forming cells was calculated by dividing the green object count (= the number of NET-forming cells) by the red object count (= the number of all neutrophils). Please click here to view a larger version of this figure.
Current methods to quantify NETs ex vivo have several drawbacks that limit our ability to study neutrophils, NETs, and potential therapeutic targets in an unbiased and high-throughput way10,14. For example, direct counting of NET-forming cells after immunofluorescent staining, considered the gold standard for quantification of NETs, is low-throughput and dependent on operator's subjective view. A plate assay detecting the fluorescence of membrane-impermeable DNA dye quantifies extracellular DNA as a surrogate marker of NETs in an objective and high-throughput manner, but since morphological information cannot be obtained by this method, DNA release by other types of cell death may be wrongly regarded as NETs. On the other hand, the method provides high-throughput and objective quantification of NETs7. Given that information about morphological changes of neutrophils and its time course can be obtained, NETs are accurately discriminated from other types of cell death. Recent papers have suggested pathogenic role of NETs in various diseases2,3,4,5, and inhibition of NETs is currently regarded as a potentially promising treatment target6. The method will be beneficial to explore multiple NET-targeting molecules in a rapid and impartial way.
There are several key points for successful quantification. Choice of membrane-permeable DNA binding dye is a very important factor for proper imaging. Some dyes are cytotoxic, and other dyes take time to permeate into nuclei. Since NET formation is relatively rapid, the dye must permeate into the nuclei quickly. We chose a nuclear red dye (see Table of Materials) taking these factors into consideration. The number of cells in each well is also important for accurate counting. If it is too crowded, green and red signals of each neutrophil will overlap with each other, which makes it difficult to separately count each neutrophil.
There are a few limitations to this method. While intra-assay variability is excellent in this assay, inter-assay variability is unclear. This is because neutrophils, even when isolated from the same donor with all conditions kept consistent, act differently on different days and there may be some variation between assays performed on another day. Therefore, if data from different days needs to be combined, it is necessary to carefully design the assay: for example, to include the same number of samples from disease and control groups on each day. In addition, although the evaluation of NET formation is objective once the analysis definition is defined (step 3), setting the definition itself somewhat depends on the subjective view of each operator. Steps 3.3 and 3.4 are the critical steps to exclude subjective judgments and keep inter-assay variability as small as possible. Also, a positive control (e.g., neutrophils stimulated by 500 nM PMA or 2.5 µM calcium ionophore) must be included every time, to set the appropriate cut-off to count all NETs.
On the other hand, it must be noted that other types of cell death may be counted as NETs. When the cell membrane is breached, or DNA is released to extracellular space, green signals will be observed. When cells undergo necrotic cell death or apoptotic cells undergo secondary necrosis, their DNA will be stained by green dye7. To prevent inaccurately including these types of cell death, time course and morphological changes must be considered. While it usually takes more than 8 h for apoptotic cells to perform secondary necrosis, NET formation peaks between 3-6 h after stimulation15. Distinct morphological changes can be seen by phase contrast imaging, which is beneficial for differentiation of type of cell death7.
Overall, the method enables us to accurately quantify NETs in a high throughput and objective manner.
The authors have nothing to disclose.
We thank the Light Imaging Section in the Office of Science and Technology at the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (ZIA AR041199).
AKT inhibitor | Calbiochem | 124028 | |
Clear 96-well plate | Corning | 3596 | |
Live cell analysis system | Sartorius | N/A | Incucyte Software (v2019B) |
Membrane-impermeable DNA green dye | Thermo Fisher Scientific | S7020 | |
Nuclear red dye | Enzo | ENZ-52406 | Neutrophil pellet becomes bluish after staining. |
RPMI | Thermo Fisher Scientific | 11835030 | Phenol red containig RPMI can be used. |